Unsupervised Machine Learning Identifies Treatment Response to Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: A TOPCAT Substudy - 26/07/19
Doi : 10.1016/j.hlc.2019.06.146
S. Nanayakkara 1, 2, 3, ⁎, A. Beale 1, 2, 3, M. Inouye 2, 4, 5, D. Kaye 1, 2, 3
1 The Alfred, Melbourne, Australia
2 Baker Heart and Diabetes Institute, Melbourne, Australia
3 Monash University, Melbourne, Australia
4 University of Cambridge, Cambridge, United Kingdom
5 Alan Turing Institute, London, United Kingdom
⁎Corresponding author.
Il testo completo di questo articolo è disponibile in PDF.
© 2019
Pubblicato da Elsevier Masson SAS.
Vol 28 - N° S4
P. S196 - 2019 Ritorno al numero
Articolo precedente
- Understanding the Prevalence and Patient Characteristics of Pulmonary Hypertension According to the Updated Haemodynamic Definition
- N. Bart, S. Hungerford, K. Kearney, K. Brown, C. Corrigan, A. Keogh, E. Kotlyar
- Uptake of Influenza, Pneumococcal and Herpes Zoster Vaccination as a Preventative Strategy for Adverse Cardiovascular Outcomes in a High-Risk Cohort of Patients with Chronic Heart Failure
- M. Thangarajah, R. Porter, R. MacIntyre, T. Tan
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?